RBCC: 3D Bioprinting Tech Ushers In Future Of Medicine
MIRAMAR BEACH, Fla.--(BUSINESS WIRE)--The BiO Assay, a magnetic 3D bioprinting system being marketed and developed by Rainbow Coral Corp. (OTCBB: RBCC) and joint venture partner Nano3D Biosciences (n3D), is the first designed specifically for rapid, high-volume drug screening—ushering in an exciting new era in medicine.
Help employers find you! Check out all the jobs and post your resume.